The Weekend Effect on Morbidity and Mortality Among Pediatric Epilepsy Admissions

Timothy Wen1, Daniel R Kramer2, Steve Sirot2

  • 1Keck School of Medicine of USC, University of Southern California, Los Angeles, California.

Pediatric Neurology
|July 6, 2017
PubMed

Insights

Pediatric epilepsy patients admitted on weekends face higher risks of hospital-acquired conditions and inpatient mortality. This study highlights a significant disparity in outcomes for weekend admissions compared to weekday admissions.

Area of Science:

  • Neurology
  • Pediatric Medicine
  • Healthcare Quality

Background:

  • Pediatric epilepsy is a common neurological disorder with significant morbidity.
  • Weekend hospital admissions are linked to poorer outcomes in general.
  • No prior studies examined weekend admission impact on pediatric epilepsy patients.

Purpose of the Study:

  • To assess the association between weekend admission and clinical/quality outcomes in pediatric epilepsy hospitalizations.
  • To identify disparities in care for pediatric epilepsy patients admitted on weekends versus weekdays.

Main Methods:

  • Utilized the 2000-2009 Kids Inpatient Database for pediatric epilepsy discharges.
  • Identified hospital-acquired conditions using ICD-9-CM codes.
  • Conducted multivariable analyses to compare weekend vs. weekday admission outcomes.

Main Results:

  • Analyzed 526,765 pediatric epilepsy discharges; 20% admitted on weekends.
  • Weekend admissions showed 28% higher hospital-acquired condition rates and 21% higher inpatient mortality.
  • Non-pediatric centers had lower mortality but higher hospital-acquired condition rates.

Conclusions:

  • Weekend admission in pediatric epilepsy is significantly associated with worse clinical and quality outcomes.
  • Potential factors include unplanned admissions and reduced staffing on weekends.
  • Further research is needed to address these disparities in this vulnerable population.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
334
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
381
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377